Back

Risk of progression to malignant ventricular arrhythmia's in carriers of the cardiomyopathy causing (PLN) p.Arg14del mutation

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated ePosters 8: channelopathies & cardiomyopathies Other Genetic Variants EHRA Premium Access EHRA 2019

About the speaker

Photo
Mr Tom Verstraelen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Ethnical differences in patients with brugada syndrome and arrhythmic events: new insights from sabrus
Doctor A. Milman (Beer Yakov, IL)
Abstract Slides
Presentation thumbnail
Genotype-phenotype correlations in patients with arrhythmogenic cardiomyopathy: results from next generation sequencing in a large multicenter cohort
Assistant Professor A. Saguner (Zurich, CH)
Abstract
Presentation thumbnail
Safety of general anesthesia in brugada syndrome
Doctor G. Ciconte (San Donato Milanese, IT)
Abstract Slides
Presentation thumbnail
Prognostic implications of non-sustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy
Doctor C. Adduci (Rome, IT)
Abstract
Presentation thumbnail
Large repolarization gradients increase susceptibility to trigger-induced arrhythmias and are not reflected by QT time
Doctor M. Cluitmans (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters 8: channelopathies & cardiomyopathies

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Presentation
Genetic approaches to restore cardiac conduction and prevent ventricular arrhythmias
thumbnail
Congress Presentation
Inherited arrhythmias: novel disease mechanisms in cardiomyocytes and beyond

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources